Sign in

Chiara Corti, MD

@ccortimd.bsky.social
546 followers 238 following 37 posts

MD • Breast Medical Oncologist from @IEOufficiale • Research Fellow @DFCI_BreastOnc • Editor @PLOSDigiHealth • Epistemic diversity enthusiast. • #FirstGen • Rock lover 🎸

PostsRepliesMedia
Chiara Corti, MD @ccortimd.bsky.social · 29/05/2025
🔬 I’ll be at #ASCO25 to discuss the differential genomic landscape of ER-low vs ER+ and ER- m+ #breastcancer. Join the conversation at Poster Board 50 on 6/2/25, 9:00 AM–12:00 PM! #bcsm @danafarber.bsky.social @danafarbernews.bsky.social @ascocancer.bsky.social www.asco.org/abstracts-pr...
asco.org
Differential genomic landscape of estrogen receptor (ER)-low versus ER-positive (ER+) and ER-negative (ER-) metastatic breast cancer (MBC). - ASCO
150
Chiara Corti, MD @ccortimd.bsky.social · 21/05/2025
Try and play with it. All the feedback will be welcomed by @ascocancer.bsky.social and @newsfromgoogle.bsky.social ! ASCO Guidelines Assistant is available to anyone with an ASCO account until June 8, 2025. After this date, use of this tool is an exclusive benefit for ASCO members.
030
Chiara Corti, MD @ccortimd.bsky.social · 15/05/2025
🚨NEW @ascocancer.bsky.social #EduBook chapter: @hoperugo.bsky.social, @stolaney1.bsky.social & I unpack the most debated trial design issues in m+ #BreastCancer —suboptimal control arms, crossover challenges, post-progression tx, non-inferiority margins, patient selection. ➡️ shorturl.at/nZWdI #bcsm
shorturl.at
Decoding Clinical Trials in Metastatic Breast Cancer: Practical Insights for Optimal Therapy Sequencing
The art of sequencing therapy in the management of breast cancer is a multifaceted challenge that demands the careful integration of clinical trial data, real-world evidence, and individualized patien...
030
Chiara Corti, MD @ccortimd.bsky.social · 25/04/2025
In medio stat virtus
020
Chiara Corti, MD @ccortimd.bsky.social · 23/04/2025
Scientific publishers are under siege by distant buyers, flipping journals to #OpenAccess and raising APCs. @Nature article explains the game: “Invasion of the ‘journal snatchers’: the firms that buy science publications and turn them rogue” www.nature.com/articles/d41...
nature.com
Invasion of the ‘journal snatchers’: the firms that buy science publications and turn them rogue
Study finds dozens of journals that have hiked their fees and started churning out papers after being acquired by small, recently formed companies.
011
Chiara Corti, MD @ccortimd.bsky.social · 22/04/2025
“Education is one of the few forces powerful enough to break the cycle of #poverty. It gives children born into hardship the tools to rewrite their story—and shape a future of their own making.”
000
Reposted by Chiara Corti, MD
Dana-Farber’s Breast Oncology Center @dfcibreastonc.bsky.social · 15/04/2025
Don't miss this newly published review discussing recent advances in immune checkpoint inhibitors for #TripleNegativeBreastCancer. 🔓 pubmed.ncbi.nlm.nih.gov/40196378/ @ccortimd.bsky.social @stolaney1.bsky.social #TNBC #BreastCancer
056
Reposted by Chiara Corti, MD
mitcriticaldata.bsky.social @mitcriticaldata.bsky.social · 12/04/2025
www.sciencedirect.com/science/arti... If your business model is still selling algorithms, please stop. The accuracy of models is limited in time and space. The pursuit of generalizability is misguided. AI should be local, iterative, reflective and reflexive.
sciencedirect.com
Global disparities in artificial intelligence-based mammogram interpretation for breast cancer: A scientometric analysis of representation, trends, and equity
Breast cancer (BC) is the most frequently diagnosed cancer and the leading cause of cancer death among women worldwide. Artificial intelligence (AI) s…
111
Chiara Corti, MD @ccortimd.bsky.social · 12/04/2025
"Global disparities in artificial intelligence-based mammogram interpretation for breast cancer: A scientometric analysis of representation, trends, and equity" shorturl.at/Q7xFo .
130
Chiara Corti, MD @ccortimd.bsky.social · 06/04/2025
From #immunotherapy (IO) failures to new strategies & biotech innovations in metastatic TNBC, to IO timing, chemo backbones, & novel approaches in the early stage. All this & more in our latest review on immune checkpoint inhibitors in #TNBC. shorturl.at/izpbe @dfcibreastonc.bsky.social
064
Chiara Corti, MD @ccortimd.bsky.social · 26/03/2025
Great to stop by #USCAP25 this afternoon to support our team’s work using #MachineLearning to characterize the tumor microenvironment in post-surgical #TNBC specimens after neoadjuvant chemo. @dfcibreastonc.bsky.social @uscap.org
052
Chiara Corti, MD @ccortimd.bsky.social · 05/01/2025
AI-generated content floods literature with poor-quality publications, casts doubt on metrics, @science.org and Retraction Watch investigation finds. www.science.org/content/arti...
science.org
Shoddy commentaries—a quick and dirty route to higher impact numbers—are on the rise
AI-generated content floods literature with poor-quality publications, casts doubt on metrics, Science and Retraction Watch investigation finds
010
Chiara Corti, MD @ccortimd.bsky.social · 24/12/2024
Merry Christmas to all. Health truly is our most precious gift - It’s not just a cliché. For some, this season means remembering a loved one, facing a tough diagnosis, starting a new treatment, or getting difficult scan results. My heart is with you. ❤️
010
Chiara Corti, MD @ccortimd.bsky.social · 23/12/2024
🚨 NY Gov. Kathy Hochul signs bill mandating private insurers cover scalp cooling systems starting Jan 1, 2026. 👏 First state to do so—hopefully paving the way for universal access. #CancerCare #HealthEquity #bcsm shorturl.at/AXNdm
shorturl.at
Breakthrough law offers cancer patients in New York relief for 'scalp-cooling therapy'
New York has become the first state in the country to require insurance coverage for what's called "scalp-cooling therapy," which can reduce hair loss for chemo patients.
050
Reposted by Chiara Corti, MD
Sarah Sammons MD @drsarahsammons.bsky.social · 13/12/2024
Great work showing half of patients with metastatic relapse after adjuvant abemaciclib have loss of estrogen expression. Biopsy remains critical. #sabcs24 @oncbrothers.bsky.social
0122
Reposted by Chiara Corti, MD
Guilherme Nader Marta @guinadermarta.bsky.social · 13/12/2024
Post-hoc TAILORx analysis: In HR+/HER2-, LN- breast cancer w/ RS ≥31, anthracycline (T-AC) improved 5-year DRFI (96% vs 91%, aHR 0.32, p=0.009) and DRFS vs TC. Benefit strongest in tumors >2cm, increasing with RS Results are alligned w/ other MammaPrint High 2 results @oncoalert.bsky.social
0106
Chiara Corti, MD @ccortimd.bsky.social · 13/12/2024
Join us in Row 10 to see our poster on outcomes in HER2+ & TNBC pts treated with neoadjuvant tx! Key findings: ✅ pCR linked to better outcomes ✅ 3-yr RFS/OS varied by cT, cN, & subtype at dx ✅ In RD pts, cT, cN, & subtype stayed prognostic, but not in pCR pts (few events) #SABCS24 #bcsm
041
Chiara Corti, MD @ccortimd.bsky.social · 13/12/2024
Thank you all for stepping by and chatting with me yesterday. Thanks to @dfcibreastonc.bsky.social , my mentor @stolaney1.bsky.social , and all the co-authors for this great opportunity 😊 #SABCS2024 @sabcs.bsky.social
1102
Reposted by Chiara Corti, MD
Dana-Farber’s Breast Oncology Center @dfcibreastonc.bsky.social · 11/12/2024
Don’t miss #SABCS24 Clinical Controversies Session on: Omission of Axillary Staging in ER-Positive #BreastCancer - Implications on Adjuvant Therapies, where Dr. Elizabeth Mittendorf will discuss the current data.
011
Chiara Corti, MD @ccortimd.bsky.social · 11/12/2024
Please join us for the poster session today at 12.30PM! Our work on patients who experienced recurrence on adjuvant abemaciclib is in Row 9, right in front of the exhibitors. We look forward to chatting with you! @sabcs.bsky.social @dfcibreastonc.bsky.social
031
Reposted by Chiara Corti, MD
Dana-Farber’s Breast Oncology Center @dfcibreastonc.bsky.social · 11/12/2024
Meet Chiara Corti, MD(@ccortimd.bsky.social)! She came to Dana-Farber from IEO and the Università degli Studi di Milano. Now a #DFCIAdvancedFellow her research focuses on optimizing #BreastCancer treatment via tumor & microenvironment profiling and leveraging AI to streamline clinical operations.
111
Reposted by Chiara Corti, MD
Guilherme Nader Marta @guinadermarta.bsky.social · 11/12/2024
Biomarker analyses of KN-522 shows most markers (T-cell GEP, HRD, HER2 signaling, PTEN, TNBC subtype) were prognostic but not predictive High TMB showed a signal for pembro benefit, but only in 8% of pts Predictive biomarkers for ICI in early TNBC are urgently needed! @oncoalert.bsky.social
194
Chiara Corti, MD @ccortimd.bsky.social · 11/12/2024
Don’t miss tomorrow’s poster session, with a stellar team! Honored to present with @dfcibreastonc.bsky.social #SABCS2024 @sabcs.bsky.social
043
Reposted by Chiara Corti, MD
Erika Hamilton MD, FASCO @erikahamilton9.bsky.social · 10/12/2024
Dr. Dos Santos presents data around how the breast is changed during pregnancy...and persists (not just during pregnancy)! 🤰 May explain why parity and age impacts breast cancer risk 📊. Early pregnancy ⬇️ breast cancer risk by 30-40% #SABCS24 @sabcs.bsky.social @oncoalert.bsky.social #bcsm
0105
Reposted by Chiara Corti, MD
NEJM.org @nejm.org · 06/12/2024
Hello, #MedSky community! We’re excited to begin our Bluesky journey. Here is a sampling of the trusted, influential, and essential information you can expect when you follow us:
32860187
Chiara Corti, MD @ccortimd.bsky.social · 05/12/2024
Finally also the amazing @dfcibreastonc.bsky.social group has joined @bsky.app ! Follow this account 👆🏻 for the latest news regarding #breastcancer meetings, clinical trial related info, new research coming out and much more !
000
Reposted by Chiara Corti, MD
San Antonio Breast Cancer Symposium @sabcs.bsky.social · 27/11/2024
We are looking forward to this year's San Antonio Breast Cancer Symposium which starts on December 10. Take a look at the full program for this important meeting featuring the latest research on breast cancer. sabcs.org/FullProgram #SABCS24 #breastcancer
04412
Chiara Corti, MD @ccortimd.bsky.social · 27/11/2024
Thrilled to see this labor of love finally out! Many thanks to the amazing and incredibly patient @myESMO publishing team for their support in bringing together diverse perspectives throughout the drafting, editing, and proofreading process. #bcsm #ESMO oncologypro.esmo.org/education-li...
oncologypro.esmo.org
Breast Cancer: Essentials for Clinicians Second Edition
Each chapter of this book reflects the latest standards of care in breast cancer management, providing new insights into diagnosis and treatment.
031
Chiara Corti, MD @ccortimd.bsky.social · 27/11/2024
One of the reasons why epistemic diversity is key to good teams and collaborations
021
Reposted by Chiara Corti, MD
WHO @who.int · 25/11/2024
It’s the International Day to End Violence against Women and Girls! 1 in 3 girls and women around the world experience physical and/or sexual violence by: A husband A boyfriend An intimate partner A lover A parent A relative A colleague A boss A stranger bit.ly/3gy8pfq #NoExcuse
1 in 3 women worldwide has experienced physical and/or sexual violence mostly at the hands of an intimate partner.
13527289
Chiara Corti, MD @ccortimd.bsky.social · 21/11/2024
Thank you, Elia, for appreciating our work!! ☺️
010
Chiara Corti, MD @ccortimd.bsky.social · 21/11/2024
I am truly grateful for the opportunity to bring together with this paper the amazing people I have had the privilege of working with in the field of #immunotherapy. #bcsm #breastcancer #OpenAccess www.cancertreatmentreviews.com/article/S030...
283
Chiara Corti, MD @ccortimd.bsky.social · 20/11/2024
An incredible day of lectures at @DanaFarber ! Dr. Disis delivered a phenomenal noon lecture on her pioneering work in cancer vaccines. 🙏🏻 #bcsm #breastcancer #dfci #cancervaccine
010
Chiara Corti, MD @ccortimd.bsky.social · 20/11/2024
Incredibly grateful for the opportunity to attend the 6th Annual Carolyn Kaelin Lecture with Dr. Kelly K. Hunt as guest speaker. A true pioneer and living legend in #breast #surgicaloncology and collaborative efforts in the field. #bcsm #BrighamWomens #DFCI #danafarber #breastcancer
061
Reposted by Chiara Corti, MD
Pills of Science🧬 @pillsofscience.bsky.social · 19/11/2024
Dopo il Guardian (che ha lasciato X per approdare su Bluesky) anche il Centro Europeo per il controllo delle malattie ECDC valuta di lasciare la piattaforma. Il livello di disinformazione è tale che anche le più grandi istituzioni sanitarie alzano bandiera bianca. www.politico.eu/article/euro...
311025239
Reposted by Chiara Corti, MD
Erika Hamilton MD, FASCO @erikahamilton9.bsky.social · 19/11/2024
Great work, thank you - starter packs were super helpful for me when I came over but weren't many hem/onc then. Here are a couple more: @joshdragomd.bsky.social @eschattner.bsky.social @ccortimd.bsky.social @antoniopassaro.bsky.social @rsm2800.bsky.social @leonidasplatan1.bsky.social
361
Reposted by Chiara Corti, MD
Dr. RShatsky @dr-rshatsky.bsky.social · 17/11/2024
Ok #OncSky and #BCSM #SABCS24 is coming up! We used to post updates of important studies and abstracts we find practice changing on X, but I’d love it if we could do that here. Who wants to join me in this?
9437
Chiara Corti, MD @ccortimd.bsky.social · 19/11/2024
“We need #women who are so strong they can be #gentle, so #educated they can be #humble, so fierce they can be #compassionate, so #passionate they can be #rational, and so disciplined they can be #free.” ― Kavita N. Ramdas
151